Last update Dec. 21, 2021
We do not have alternatives for Fludrocortisone Acetate.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Fludrocortisone Acetate is also known as
Fludrocortisone Acetate in other languages or writings:
Fludrocortisone Acetate belongs to these groups or families:
Main tradenames from several countries containing Fludrocortisone Acetate in its composition:
|Protein Binding||70 - 80||%|
|Tmax||0.5 - 1.7||hours|
|T½||1.3 - 3.5||hours|
Write us at email@example.com
e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Steroidal drug with glucocorticoid action and high activity as mineralocorticoid. Systemic administration: oral route. Indicated as replacement therapy in Adrenal Insufficiency (Addison’s Disease) and "salt-losing" Congenital Adrenal Hyperplasia. Topical administration: creams as dermatologic compounds and eye drops for ophthalmologic use.
At latest update relevant published data were not found on excretion into breast milk.
Other corticosteroids are know to be excreted into breastmilk in small amounts.
Since the goal of treatment is to keep the mother within normal plasma hormone ranges, by monitoring adequately through analytical controls to make sure the mother is receiving a correct dose, it would neither interfere with breastfeeding nor would be harmful to the infant.
Take as lowest effective dose as possible with follow-up the infant for hypo-adrenal signs.
TOPICAL ADMINISTRATION (dermatologic and ophthalmologic use):
The small dose used along with a poor passage to plasma of most ophthalmologic and topical dermatologic preparations makes it very unlikely that a significant excretion into breastmilk would occur.
Do not apply on the breast to prevent ingestion by the infant; otherwise, do it just after a meal and clean the nipple thoroughly with water before the next feed.
Mineral-corticoid poisoning occurred in an infant after long-term application of a corticoid cream on the nipple. (De Stefano 1983)